Author: Fahim journalist
-
AB Stock in 2025: Yielding Value or Just Another Wall Street Hold?
Alliance Bernstein Holding L.P. (NYSE: AB) continues to draw attention in 2025 as a dividend-heavy, asset-management-focused investment. With a historically strong yield and a reputation for sound institutional investing, the stock remains a staple in income-oriented portfolios. But with market volatility, rising competition in wealth management, and evolving macroeconomic headwinds, investors are asking: Is AB…
-
Inside Bezos’ Star‑Studded Wedding Guestlist: Who Made the Cut and Who Didn’t
Jeff Bezos and Lauren Sánchez’s ultra‑exclusive 2025 nuptials weren’t just a social event—they were a barometer of fame, fortune, and geopolitical clout. In the age of influencers, billionaire space races, and viral red‑carpet livestreams, a single Guestlist can reveal more about Hollywood–Silicon Valley power structures than any corporate filing or movie premiere. This deep‑dive unpacks…
-
Rate Rift at the Fed: Inside the Battle Over a July Cut
The U.S. Federal Reserve is once again at a crossroads. As the economy walks a tightrope between inflation concerns and slowing growth, internal divisions within the central bank are surfacing with renewed intensity. Prominent officials like Governor Michelle Bowman and Governor Christopher Waller have voiced support for a July interest rate cut, while others advocate…
-
Stagflation Strikes Back? Inside the Economic Tug‑of‑War Driving Market Jitters
Economists warned for years that the post‑pandemic economy might stall into a rare, painful mix of stagnant growth and stubborn inflation. By mid‑2025, data points—including two consecutive quarters of sub‑1 % GDP growth and core CPI still hovering near 4 %—suggest that dreaded word is no longer hypothetical: stagflation. What Exactly Is Stagflation? Definition and Origins Coined…
-
The Cost of Delay: How Braga’s Pushback Impacts Microsoft’s AI Ambitions
Understanding “Braga”: Microsoft’s Ambitious AI Silicon What is Braga? Deciphering Microsoft’s Custom AI Chip: Data Point 1: Technical specifications (if available from reliable sources – e.g., expected core count, architecture, target performance). Data Point 2: Its intended purpose (e.g., accelerating large language models, powering Azure AI services). The Strategic Imperative: Why Microsoft Needs Its Own…
-
Data, Bias, Power: Inside the Tug-of-War Over AI Governance in the Age of Agents
Artificial intelligence (AI) is no longer a frontier technology. It is woven into every layer of modern society—from how we work and shop to how wars are fought and democracies operate. With the rise of autonomous AI agents, the stakes surrounding AI governance have grown exponentially, bringing an urgent need for clear ethical frameworks, regulatory…
-
From Deductions to Detentions: The Political Stakes of the Latest Tax and Immigration Bill
In an unprecedented move, congressional leaders have bundled sweeping tax reforms with aggressive immigration measures into a single legislative package—informally nicknamed the “Tax & Immigration Bill.” Supporters hail it as a grand compromise that balances economic growth with border security. Critics call it a hostage situation, pairing unrelated agendas to force difficult votes. This deep…
-
Disconnected: What the Closure of a Vital LGBTQ Youth Hotline Says About Policy in 2025
In early 2025, a critical mental health and crisis support line specifically serving LGBTQ youth across the United States was quietly shut down due to funding disputes and increasing political polarization. The hotline, which had previously fielded thousands of calls monthly from at-risk youth, many in rural or conservative areas, ceased operations without clear contingency…
-
Is JN.1 the New Threat? Scientists Break Down the Latest COVID Evolution
As the global health community continues to monitor emerging COVID-19 variants, a new lineage known as JN.1 is raising fresh concerns. First identified in late 2024, this subvariant has rapidly spread across multiple countries and is showing signs of heightened transmissibility. Health authorities—including the CDC, WHO, and various genomic surveillance networks—are closely tracking its behavior…
-
Is Nimbus the Future of Personalized Medicine? Here’s What Experts Say
Personalized medicine is no longer a concept of the future—it’s becoming the standard. In the midst of this transformation, one name continues to draw attention in the health tech and biotech industries: Nimbus. Whether referring to Nimbus Therapeutics, known for its cutting-edge drug development platforms, or Nimbus Health, a digital health platform redefining cannabinoid-based treatments…